Consortium Lead Team Members
Mr. Paul Lalvani, Pharmacist, MBA (Kellogg), Executive Director RaPID Pharmacovigilance Program
Paul Lalvani is a pharmacist with 20 years of experience in healthcare and management, which includes work in public and private sector, and in developed and developing countries, including USA, Japan, India, Nigeria, Afghanistan, Vietnam, Papua New Guinea, Yemen, Egypt, among others.
He has advised several governments on their national drug supply systems and is on the board of advisors Medicines for Malaria Venture, WHO's Global Malaria Program. At present, Mr. Lalvani is consulting to the Gates Foundation and some Ministries of Health. Previously, he was the head of Global Fund's Procurement and Supply Chain Management Group; a Country Director for one of Management Sciences for Health's (MSH) country project; a clinical pharmacist at Humana Hospital, and some other positions. In addition to his pharmacy degree, Mr. Lalvani holds a master's degree in business administration (MBA) from Northwestern University's Kellogg School of Management.
--------------------------------------------------------------------------------------------------------------------------------------------
Dr. Eva M A Ombaka, Coordinator, EPN, Kenya.
Dr Ombaka was trained as a pharmacist at University of Aston in Birmingham, UK where she also did her PhD research in Pharmaceutical Microbiology. Her 30-year carreer in pharmacy spans from hospital practice, academia, and manufacturing. In the last fourteen years she has been involved in pharmaceutical policy development, advocacy and capacity building for people in practice. Her main advocacy areas are in the field of access to medicines. She is currently the coordinator of the Ecumenical Pharmaceutical Network (EPN) that brings church-related health services around the world to address pharmaceutical issues together. She is an honorary pharmaceutical adviser to the World Council of Churches. She is also involved in the work of Sustainable Healthcare Enterprises Foundation (SHEF) that is pioneering the franchising of community-based pharmaceutical services to enable access to essential medicines and other basic health services.
Dr. Ombaka is a Tanzanian but is currently working and living in Nairobi, Kenya.
--------------------------------------------------------------------------------------------------------------------------------------------
Dr. Alex Dodoo, PhD, MPSGH, MRPharmS, Ag. Director CTCPT, University of Ghana Medical School
Dr Alexander Nii Oto Dodoo is a Senior Research Fellow and the Acting Director at the Centre for Tropical Clinical Pharmacology & Therapeutics (CTCPT) of the University of Ghana Medical School. He undertook his undergraduate (B. Pharm degree) at the University of Science and Technology, Kumasi Ghana and his postgraduate training (M.Sc. and Ph.D.) at the Department of Pharmacy, King’s College London. UK. Dr Dodoo worked as a Senior Scientist at Roche Discovery Welwyn, UK from 1996-1998 and as a community pharmacist in England in 1999.
Dr Dodoo was instrumental in setting up the Ghana National Centre for Pharmacovigilance in 2001, the first such centre in West Africa. His main research interests are in pharmacovigilance including safety monitoring of vaccines, anti-malarials and anti-retrovirals. Dr Dodoo is an Executive Committee Member of the International Society of Pharmacovigilance. He is the President of the Pharmaceutical Society of Ghana and also President of the Pharmacy Information Section of the International Pharmaceutical Federation and the co-Chairman of the Ghana Chapter of the Medicines Transparency Alliance (MeTA). He a member of the Executive Committee of the Intentional Society of Pharmacovigilance and a Member of the Advisory Committee on Focus on Artemisinin-based Combination Therapy (FACT) of the DNDi.
--------------------------------------------------------------------------------------------------------------------------------------------
Dr. Jawahar Bapna, MD, PhD, Advisor, RaPID Pharmacovigilance Program, IIHMR, and Adjunct Professor
Jawahar S. Bapna, MSc (Med), PhD, Professor at Indian Institute of Health Management Research, has been a member of pharmacovigilance committees of Government of India and the Indian Council of Medical Research. He has been a consultant for the research projects with agencies like WHO, World Bank, EU, Euro Health Group, DANIDA and MSH. He is an experienced trainer and has conducted a number of training programs on rational use of drugs including pharmacovigilance.
| 
